Device Trial Radar · NCT05662059
Respiratory-gated Auricular Vagal Afferent Nerve Stimulation (RAVANS) Study in Ulcerative Colitis
Last checked: Nov 20, 2026Latest source record: Oct 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
30
Actual
Start
Jan 12, 2023
Primary completion
Apr 15, 2026
Study completion Apr 15, 2026
Sponsor
- Lead sponsor
- Cala Health, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Dec 22, 2022
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Other
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 10 years, up to 39 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Prospective, single-center, sham-controlled, double-blinded 12-week study designed to evaluate the safety and efficacy of the RAVANS device in subjects with Ulcerative Colitis. The goal of the study is to distinguish sham (no stimulation) versus treatment (stimulation) response and to identify treatment responders. The study will last 12 weeks with in-clinic visits at 0 weeks and 12 weeks, and a telehealth-visit at week 6. Additionally, unscheduled visits may occur based on the needs of the subject or at the discretion of the investigator. Subjects will be randomized 2:1 to treatment or sham, and will stimulate at home twice per day.
Conditions
- Ulcerative Colitis
Interventions
RAVANSDevice
Respiratory-Gated Auricular Vagal Afferent Nerve Stimulation
RAVANS-shamDevice
RAVANS sham device
Primary outcomes
What the sponsor says the trial is designed to measure.
- Clinical RemissionTime frame: 12 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Feinstein Institute for Medical Research at Northwell Health
Lake Success, New York
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.